Sustaining synergy & distinction in science

Sustaining synergy & distinction in science

Enhancing clinical effectiveness

Our goal is to improve the performance of existing treatments for certain autoimmune diseases and cancers. We plan to achieve this by developing and commercializing new drug dosage forms, concentrations, and modes of delivery. These modifications can potentially improve the safety profile, bioavailability, tolerability, and efficacy of existing medications, leading to better patient compliance and improved patient outcomes.